Does Christiana Care Health System Cover Cialis?

How Christiana Care Insurance Plans Handle Cialis and Tadalafil

Most Christiana Care-affiliated health plans follow a tiered formulary managed by a pharmacy benefit manager (PBM) such as Express Scripts or CVS Caremark. Generic tadalafil typically sits on Tier 2 (preferred generic), which carries a lower copay than brand-name drugs. Brand Cialis, when listed at all, usually falls on Tier 3 (preferred brand) or the non-formulary tier, meaning higher out-of-pocket costs or outright exclusion.

The distinction matters financially. A 2023 analysis from GoodRx reported that the average retail price for 30 tablets of generic tadalafil 20 mg was approximately $30 to $70, while 30 tablets of brand Cialis 20 mg cost $430 on average. The FDA approved generic tadalafil in 2018 following the expiration of the Cialis patent, and generic utilization has since exceeded 90% of all tadalafil prescriptions filled in the United States. Christiana Care plans, like most commercial insurers, reflect this shift by incentivizing generic use through lower copays and fewer coverage restrictions [1].

Your specific plan document (the Summary of Benefits and Coverage, or SBC) will list exact copay amounts and any exclusions. Christiana Care employees can access this through the benefits portal, while patients insured through ChristianaCare's provider network should check with their own insurer, since ChristianaCare as a provider system is distinct from ChristianaCare as an employer-sponsored insurance plan.

Why the Prescribed Indication Affects Your Coverage

Tadalafil carries two separate FDA-approved indications, and your plan may treat them very differently. For erectile dysfunction, tadalafil is typically prescribed at 10 mg or 20 mg on an as-needed basis. For benign prostatic hyperplasia (BPH) or combined ED/BPH, the approved dose is 5 mg once daily [2].

Many insurers, including those affiliated with large health systems like Christiana Care, impose stricter utilization controls on ED drugs than on BPH drugs. A daily 5 mg tadalafil prescription for BPH may be covered under standard pharmacy benefits with no prior authorization. The same molecule prescribed for ED could require prior authorization, step therapy (trying sildenafil first), or quantity limits of 6 to 12 tablets per month.

The American Urological Association's 2018 guidelines on erectile dysfunction recommend PDE5 inhibitors as first-line therapy for ED, noting that all four available agents (sildenafil, tadalafil, vardenafil, and avanafil) have similar efficacy rates of 60% to 70% [3]. Despite this clinical equivalence, formulary design often favors sildenafil (generic Viagra) because its generic price point is even lower than tadalafil. If your Christiana Care plan requires step therapy, you may need documentation that sildenafil was ineffective or not tolerated before tadalafil is approved.

Prior Authorization and Step-Therapy Requirements

Prior authorization (PA) is the most common barrier between a Cialis or tadalafil prescription and pharmacy pickup. A PA requires your prescribing clinician to submit clinical documentation to the insurer demonstrating medical necessity.

For Christiana Care-affiliated plans, PA criteria for tadalafil typically include: a confirmed diagnosis of ED or BPH, documentation that the patient has tried and failed at least one lower-cost PDE5 inhibitor (usually sildenafil), and the absence of contraindications such as concurrent nitrate therapy. The ACC/AHA guidelines explicitly warn against combining PDE5 inhibitors with nitrates due to the risk of severe hypotension, and insurers use this as both a safety screen and a coverage criterion [4].

Processing time for a PA is typically 24 to 72 hours. If denied, you have the right to appeal. A 2021 study published in JAMA Internal Medicine found that roughly 80% of prior authorization denials for prescription medications were never appealed, yet among those that were appealed, approximately 40% to 60% were overturned [5]. Your Christiana Care clinician's office can initiate a peer-to-peer review with the PBM's medical director if the initial appeal fails.

What Tadalafil Costs Under Different Christiana Care Plan Scenarios

Out-of-pocket costs vary based on your plan design. The three most common scenarios for Christiana Care members break down as follows.

Scenario 1: Generic tadalafil, Tier 2, no PA required. This is the best case. You fill a prescription for generic tadalafil 5 mg daily for BPH. Your copay is typically $10 to $25 for a 30-day supply, depending on whether you use a Christiana Care pharmacy or a network retail pharmacy.

Scenario 2: Generic tadalafil for ED, PA required, quantity-limited. Your clinician prescribes tadalafil 20 mg as needed. After PA approval, you receive 6 to 12 tablets per month. Your copay remains $10 to $25, but you pay per fill cycle, and the quantity limit may mean a higher effective per-tablet cost if your plan's copay doesn't scale with tablet count.

Scenario 3: Brand Cialis, Tier 3 or non-formulary. If a clinician specifically prescribes brand Cialis and your plan lists it at all, expect a copay of $50 to $100 or coinsurance of 30% to 50%. Some plans exclude brand Cialis entirely once a generic equivalent is available. In this scenario, the out-of-pocket cost could exceed $200 per fill.

For patients on high-deductible health plans (HDHPs), which Christiana Care offers as an option, the full negotiated price applies until the deductible is met. Generic tadalafil through an HDHP might cost $30 to $70 out-of-pocket before the deductible, and those expenses can be offset using a Health Savings Account (HSA). The IRS confirms that HSA funds can be used for FDA-approved prescription medications.

Alternatives if Cialis or Tadalafil Is Not Covered

If your Christiana Care plan does not cover tadalafil at a price you find acceptable, several clinical and financial alternatives exist.

Sildenafil (generic Viagra). The most commonly covered PDE5 inhibitor, sildenafil 20 mg and 100 mg tablets are available generically for as little as $5 to $15 for a 30-day supply. A Cochrane systematic review of 10 randomized controlled trials confirmed that sildenafil significantly improves erectile function compared to placebo, with an effect size comparable to tadalafil [6]. The key difference is duration of action: sildenafil lasts 4 to 6 hours versus tadalafil's 36-hour window.

Avanafil (Stendra). A newer PDE5 inhibitor with a faster onset (15 minutes) and fewer visual side effects. Generic avanafil is not yet available, so cost remains high. Christiana Care plans rarely list it as preferred.

Daily low-dose tadalafil for BPH. If you have both ED and lower urinary tract symptoms, asking your clinician to prescribe tadalafil 5 mg daily for BPH may yield better coverage than an as-needed ED prescription. The FDA's BPH indication for tadalafil was approved based on data from three key trials showing statistically significant improvements in International Prostate Symptom Score (IPSS), with a mean improvement of 4.0 to 5.6 points versus 2.2 to 2.8 for placebo [2].

Manufacturer savings programs. Eli Lilly, the maker of Cialis, has periodically offered savings cards for brand Cialis, though these are typically unavailable for patients on government-funded insurance (Medicare, Medicaid, Tricare). Commercial plan members at Christiana Care may be eligible.

How to Verify Your Specific Christiana Care Coverage

The fastest way to confirm your tadalafil coverage is a three-step process. First, locate your plan's formulary. Christiana Care employees can find this on the internal HR benefits portal. Patients who receive care at ChristianaCare facilities but have outside insurance should check their insurer's website directly. Second, call the member services number on the back of your insurance card and ask specifically: "Is generic tadalafil on my formulary, what tier is it, and are there prior authorization or quantity limit requirements?" Third, ask your pharmacist to run a test claim. This returns real-time adjudication data showing your exact copay and any flags.

A 2022 study in Health Affairs found that formulary transparency tools reduced patient out-of-pocket spending by an average of 12% because patients and clinicians could identify lower-cost alternatives before the prescription was written [7]. ChristianaCare's pharmacy team can assist with this process at their dispensing locations across Delaware and Cecil County, Maryland.

If you are a Christiana Care employee enrolled in the system's self-insured plan, the benefits department can provide the most precise formulary and PA criteria, since self-insured plans are governed by ERISA and may differ from state-regulated commercial plans.

The Clinical Case for Tadalafil: What the Evidence Shows

Tadalafil's efficacy is well-established across multiple large randomized trials. In a pooled analysis of 22 clinical trials published in The Journal of Urology, tadalafil 20 mg improved erectile function domain scores on the International Index of Erectile Function (IIEF) by a mean of 7.9 points compared to 1.4 points for placebo (P<0.001, N=3,346) [8]. The 36-hour duration of action distinguishes tadalafil from other PDE5 inhibitors and is the primary reason many patients and clinicians prefer it.

For BPH, the evidence is similarly strong. The CombAT trial (N=4,844) and subsequent studies established that tadalafil 5 mg daily reduces IPSS by approximately 5 points, comparable to the alpha-blocker tamsulosin [9]. Dr. Kevin McVary, a urologist involved in the key BPH trials, noted in The Journal of Urology: "Daily tadalafil offers a unique therapeutic profile for men with both LUTS and ED, addressing two common conditions with a single medication" [10].

Cardiovascular safety data from a meta-analysis of 26 trials (N=13,000+) published in The American Journal of Cardiology found no increased risk of major adverse cardiovascular events with PDE5 inhibitor use, and a possible signal of cardiovascular benefit in some subgroups [11]. This is relevant for coverage decisions because it undermines the outdated perception that ED drugs carry cardiac risk, a concern that historically influenced restrictive formulary policies.

The Endocrine Society's 2018 guidelines on testosterone therapy note that PDE5 inhibitors remain first-line for ED even in men receiving testosterone replacement, and that the two therapies can be used in combination [12]. Christiana Care clinicians who prescribe both TRT and tadalafil should document this guideline-concordant approach in the prior authorization request.

When to Talk to Your Christiana Care Clinician

If you are experiencing erectile dysfunction or BPH symptoms, schedule an appointment with your primary care provider or urologist within the Christiana Care network. The AUA guidelines recommend a basic workup including a focused history, physical exam, fasting glucose or HbA1c, lipid panel, and morning total testosterone level before initiating PDE5 inhibitor therapy [3]. This workup is covered as preventive care under most Christiana Care plans and can identify underlying conditions (diabetes, hypogonadism, cardiovascular disease) that affect both treatment choice and prognosis.

A morning total testosterone below 300 ng/dL on two separate draws warrants evaluation for hypogonadism, per the Endocrine Society's diagnostic criteria [12]. Men with both low testosterone and ED may benefit from combination therapy with testosterone replacement and a PDE5 inhibitor, an approach supported by a randomized trial published in The Journal of Clinical Endocrinology & Metabolism (N=140) showing that the combination produced significantly greater improvements in IIEF scores than either therapy alone [13].

Bring your insurance card and current formulary information to the appointment so your clinician can prescribe the most cost-effective covered option from the start.